Published in Clin Radiol on May 01, 1979
Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13
Orchidectomy alone for stage I testicular teratoma. Br Med J (Clin Res Ed) (1981) 1.05
Computed tomography in testicular disease: a review. J R Soc Med (1981) 0.80
Immunoscintigraphy with 131I-labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumours. Br J Cancer Suppl (1990) 0.75
Computed tomography of the body: when should it be used? Br Med J (Clin Res Ed) (1982) 0.75
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med (1990) 7.92
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst (1996) 3.53
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Male infertility due to sulphasalazine. Lancet (1979) 2.51
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol (1987) 2.34
Temperature and Excitability. J Physiol (1896) 2.21
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res (1998) 2.21
Metastatic tumours of bones of the hand and foot. A comparative review and report of 43 additional cases. Skeletal Radiol (1987) 2.14
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Comparison of mixed antiglobulin reaction and direct immunobead test for detection of sperm-bound antibodies in subfertile males. Fertil Steril (1992) 2.00
Bladder cancer as a prescribed industrial disease: a guide for clinicians. Br Med J (1980) 1.99
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
The clinical significance of antisperm antibodies in male subfertility. Br J Urol (1977) 1.84
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Sulphasalazine and male infertility: reversibility and possible mechanism. Gut (1981) 1.80
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
An effect of pactamycin on the initiation of protein synthesis in reticulocytes. Biochem Biophys Res Commun (1970) 1.79
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br Med J (Clin Res Ed) (1983) 1.67
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Features of unusual metastases from prostate cancer. Br J Radiol (1999) 1.62
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. Ann Oncol (2013) 1.62
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. J Clin Oncol (2002) 1.62
Transrectal prostatic biopsy. Br Med J (1971) 1.60
Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol (1996) 1.59
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
T.N.M. classification for urological tumours (U.I.C.C.) - 1974. Br J Urol (1975) 1.57
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol (2000) 1.54
The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol (1993) 1.52
A haematuria diagnostic service. Br Med J (1977) 1.50
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl (1980) 1.44
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Cancer (1999) 1.41
Evaluation of radiotherapy and/or surgicopathological staging after chemotherapy in the management of metastatic germ cell tumours. Br J Urol (1983) 1.40
Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys (1999) 1.39
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging (1997) 1.39
Lymphography in carcinoma of the uterus. Clin Radiol (1972) 1.38
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Role of lymphography in carcinoma of the prostate. Br Med J (1975) 1.34
Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol (2001) 1.33
Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol (1982) 1.33
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol (2006) 1.32
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer (1980) 1.31
Observations on the growth of tumours in lymph nodes changing from normal to abnormal while remaining opacified after lymphography. Clin Radiol (1968) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer (1979) 1.30
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology (1996) 1.29
Bladder cancer as a prescribed industrial disease. Br Med J (1980) 1.28
Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer (1984) 1.25
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer (1985) 1.24
Influence of tumour size on radiosensitization by misonidazole. Br J Cancer Suppl (1978) 1.24
Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. Br J Urol (1973) 1.23
delta 9-tetrahydrocannabinol in clinical oncology. JAMA (1981) 1.23
Ejaculatory duct obstruction in subfertile males: analysis of 87 patients. Fertil Steril (1991) 1.22
Testicular tumours. Clin Endocrinol Metab (1975) 1.20
The value of lymphography to the radiotherapist. Clin Radiol (1969) 1.20
Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20
Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol (1990) 1.19
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19
Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer. Br Med J (Clin Res Ed) (1985) 1.19
Fertility in men with primary ciliary dyskinesia presenting with respiratory infection. Thorax (1994) 1.19
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17
Commentary. Are current tumour response criteria relevant for the 21st century? Br J Radiol (2000) 1.17
Children fathered by men treated for testicular cancer. Lancet (1985) 1.16
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol (2008) 1.16
Comparison of ultrasound and computer-assisted tomography in pancreatic diagnosis. Br J Radiol (1977) 1.16
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study. Cancer Chemother Pharmacol (1982) 1.15
Pituitary irradiation in advanced carcinoma of the prostate: analysis of 100 cases. Br J Urol (1971) 1.15
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol (1989) 1.14